BR
BrainsWay Ltd.
BRSYF · OTC
$13.55 -10.44% (-$1.58)
Market Cap $543.8M
P/E Ratio 57.34x
Div. Yield -
ROE 12.71%
Bulios Fair Price
$13.54
0.1% downside
Current Price
$13.55
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BRSYF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
11 /100
Expensive P/FCF 94.65x
P/S 8.97x
P/B 6.86x
Growth
100 /100
Growing Book val. growth 17.28%
Rev. growth 27.65%
FCF growth N/A
Profitability
72 /100
Strong Net margin 15.65%
Op. margin 12.46%
FCF margin 9.48%
Quality
52 /100
Average ROE 12.71%
ROA 7.77%
Asset turnover 0.50x
Debt
91 /100
Low Current ratio 3.59x
Int. coverage 4.50x
Net debt/EBITDA -4.79x
Stability
43 /100
Moderate Rev. volatility 10.48%
EPS volatility 51.04%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BRSYF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Hadar Levy
Employees
129
Headquarters
Jerusalem
Upcoming events
10 NOV
Earnings
Upcoming earnings report